Human leukocyte antigen class I and II haplotypes and risk of cervical cancer

Tissue Antigens

Volumn 66, Issue 4, 2005, Pages 321-324

  Carreon, Joseph D ^a   Martin, M P ^b   Hildesheim, A ^a   Gao, X ^b   Schiffman, M ^a   Herrero, R ^c   Bratti, M C ^c   Sherman, M E ^a   Zaino, R J ^d   Carrington, M ^b   Wang, S S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c Proyecto Epidemiologico Guanacaste   (Costa Rica)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cancer; Cervix; Haplotype; Human leukocyte antigen

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ARTICLE; CANCER GRADING; CAUCASIAN; CONTROLLED STUDY; COSTA RICA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COSTA RICA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 26044449687     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00478.x     Document Type: Article

References (9)

1. Sell S, Berkower I, Max EE. Immunology, Immunopathology and Immunity, 5th edn. Stamford, CT: Appleton & Lange, 1996.
2. Wang SS, Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 2003: 31: 35-40.
3. Herrero R, Schiffman MH, Bratti C et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1997: 1: 362-75.
4. Hildesheim A, Schiffman M, Scott DR et al. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 1998: 7: 1035-41.
5. Lacey JV Jr, Brinton LA, Abbas FM et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999: 8: 1079-85.
6. Tilanus MG, Hansen JA, Hurley CK, eds. IHWG Technical Manual Genomic Analysis of the Human MHC. Seattle, WA: IHWG, 2002.
7. Wang SS, Hildesheim A, Gao X et al. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 2002: 186: 598-605.
8. http://home.ncifcrf.gov/ccr/lgd/bioinformatics/index_n.asp
9. Wang SS, Wheeler CM, Hildesheim A et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 2001: 184: 1310-4.